| Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer D Brungs, E Minaei, AK Piper, J Perry, A Splitt, M Carolan, S Ryan, XJ Wu, ... Scientific reports 10 (1), 539, 2020 | 36 | 2020 |
| Cancer progression gene expression profiling identifies the urokinase plasminogen activator receptor as a biomarker of metastasis in cutaneous squamous cell carcinoma E Minaei, SA Mueller, B Ashford, AS Thind, J Mitchell, JR Perry, ... Frontiers in oncology 12, 835929, 2022 | 12 | 2022 |
| Comprehensive mutational and phenotypic characterization of new metastatic cutaneous squamous cell carcinoma cell lines reveal novel drug susceptibilities J Perry, B Ashford, AS Thind, ME Gauthier, E Minaei, G Major, NG Iyer, ... International Journal of Molecular Sciences 21 (24), 9536, 2020 | 11 | 2020 |
| Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma AS Thind, B Ashford, D Strbenac, J Mitchell, J Lee, SA Mueller, E Minaei, ... Frontiers in oncology 12, 919118, 2022 | 8 | 2022 |
| A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review) B Genenger, JR Perry, B Ashford, M Ranson Discover Oncology 13 (1), 42, 2022 | 7 | 2022 |
| Thulium oxide nanoparticles as radioenhancers for the treatment of metastatic cutaneous squamous cell carcinoma J Perry, E Minaei, E Engels, BG Ashford, L McAlary, JR Clark, R Gupta, ... Physics in Medicine & Biology 65 (21), 215018, 2020 | 7 | 2020 |
| PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro JR Perry, B Genenger, AS Thind, B Ashford, M Ranson Cancers 16 (2), 370, 2024 | | 2024 |
| Protocol for the generation and automated confocal imaging of whole multi-cellular tumor spheroids B Genenger, L McAlary, JR Perry, B Ashford, M Ranson STAR protocols 4 (2), 102331, 2023 | | 2023 |
